Bacteriostatic Water: The Reconstitution Reference

What bacteriostatic water actually is

Bacteriostatic Water for Injection is sterile water containing 0.9% benzyl alcohol as a preservative. That single additive is the whole difference. Everything else - the water itself, the sterilisation, the packaging - matches ordinary Sterile Water for Injection.

The word doing the work is bacteriostatic, not bactericidal. Benzyl alcohol inhibits bacterial reproduction; it does not sterilise a contaminated solution and it will not rescue material that was handled poorly. It buys a multi-entry working window, nothing more. Introduce contamination on a needle and the preservative slows the consequences rather than removing them.

Bacteriostatic vs sterile water vs saline

Three fluids appear in reconstitution protocols and they are not interchangeable.

Bacteriostatic Water for Injection - sterile water + 0.9% benzyl alcohol. Suitable for multi-entry vials, which is why it is the default for any reagent used across more than one session.

Sterile Water for Injection (SWFI) - no preservative. Single-entry only. Correct where the benzyl alcohol would interfere with the assay, or where the peptide is known to be sensitive to it.

Sodium Chloride 0.9% (bacteriostatic saline) - isotonic, sometimes preferred where tonicity matters to the experimental model. Preserved and unpreserved versions both exist, so the label has to be read rather than assumed.

The practical rule: if the vial will be entered more than once, the solvent needs a preservative. If it will be used entirely in one sitting, plain SWFI removes a variable.

Why benzyl alcohol is the deciding variable

Benzyl alcohol is well characterised as a pharmaceutical preservative, which is exactly why its limitations are documented rather than theoretical.

It is not inert. For a minority of sequences it can accelerate degradation, and for assays sensitive to organic solvents it introduces a confound. Where a protocol specifies unpreserved water, that specification usually exists for a reason and substituting bacteriostatic water quietly changes the experiment.

It also has a genuine toxicology history. Benzyl alcohol preservative was implicated in neonatal 'gasping syndrome' in the early 1980s, which is why preserved diluents carry explicit population warnings in clinical contexts. That literature is not directly relevant to in-vitro laboratory work, but it is the reason the preservative is treated as an active ingredient rather than as inert filler.

Working out the volume for a target concentration

This is where most handling errors originate, and it is simple arithmetic once stated plainly.

Concentration = mass in the vial / volume of solvent added.

A 10 mg vial reconstituted with 2 ml gives 5 mg/ml. The same 10 mg vial with 1 ml gives 10 mg/ml. Nothing about the peptide changed - only the denominator.

Worked example: a 5 mg vial and a target working concentration of 2.5 mg/ml requires 2 ml of solvent. If the protocol instead calls for 1 mg/ml, the same vial takes 5 ml.

Two practical constraints. Vial headroom limits how much can be added, so very dilute stocks may not be achievable in the original container. And more dilute solutions mean larger withdrawal volumes for the same mass, which for a multi-entry vial means more entries and a shorter practical life. Choose the concentration that matches the protocol, then keep the calculation written on the vial rather than in memory.

Reconstitution technique

The failure mode in reconstitution is mechanical, not chemical. Lyophilized peptide is a fragile cake and shear forces damage it.

1. Let the vial reach room temperature before opening, so moisture does not condense onto the powder. 2. Wipe both stoppers with an alcohol swab and let them dry. 3. Draw the calculated volume of solvent. 4. Direct the stream down the inside wall of the vial, not onto the powder. This is the step that matters most. 5. Let it dissolve on its own, swirling gently if needed. Do not shake. Foaming indicates denaturation, not mixing. 6. Inspect the solution. It should be clear. Cloudiness, visible particulates or persistent undissolved material mean the vial should not be used.

Storage and working life

Unopened bacteriostatic water is stable at room temperature until its printed expiry.

After first entry, the widely used convention is a 28-day working life under refrigeration, which derives from the preservative's documented effectiveness period rather than from the peptide's stability. Whichever expires first governs.

Reconstituted peptide is the shorter-lived of the two in almost every case. Store at 2-8 degrees C, protect from light, and avoid repeated freeze-thaw cycles - each cycle costs measurable activity. Where a batch-specific Certificate of Analysis states stability figures, those take precedence over any general guidance including this page. See our peptide storage and handling guide for compound-level detail and how to read a COA for interpreting batch documentation.

Conclusion

Bacteriostatic water is the least glamorous item in a peptide workflow and one of the few where the correct choice is unambiguous: preserved solvent for multi-entry vials, unpreserved for single use, and the label read rather than assumed. The arithmetic is trivial, the technique is mechanical, and both are worth getting right because every downstream measurement inherits the error.

The reagent itself is a lab consumable rather than a research compound, and it carries none of the regulatory complexity of the peptides it dissolves. That does not make it optional - a correctly synthesised, correctly certified peptide can still be ruined in the thirty seconds it takes to reconstitute it badly.

Frequently Asked Questions